Bioconversion of compactin into pravastatin by Streptomyces sp.

  • Joo Woong Park
  • , Joo Kyung Lee
  • , Tae Jong Kwon
  • , Dong Hee Yi
  • , Young Jun Kim
  • , Seong Hoon Moon
  • , Hyun Hyo Suh
  • , Sang Mo Kang
  • , Yong Il Park

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Abstract

Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l-1 from 750 mg compactin l-1 in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l-1 and 1000 mg pravastatin l-1, respectively, with the conversion rate of 10 mg l-1 h-1. Continuous feeding of compactin increased production of pravastatin to 15 mg l -1 h-1.

Original languageEnglish
Pages (from-to)1827-1831
Number of pages5
JournalBiotechnology Letters
Volume25
Issue number21
DOIs
StatePublished - Nov 2003

Keywords

  • Bioconversion
  • Compactin
  • Cytochrome P-450
  • Pavastatin
  • Streptomyces sp.

Fingerprint

Dive into the research topics of 'Bioconversion of compactin into pravastatin by Streptomyces sp.'. Together they form a unique fingerprint.

Cite this